Introduction
Articular cartilage is avascular tissue composed of chondrocytes within an extracellular matrix of collagen and proteoglycans present at the surface end of long bones 1 . Articular cartilage is responsible for providing a frictionless bearing surface and absorbing and transmitting tensile, compressive and shear forces 1 . Congenital anomalies, degenerative joint disease and traumatic injuries cause damage to articular cartilage causing a large social and economic medical problem for many individuals throughout a variety of age groups 1 . Unfortunately, adult articular cartilage has a limited capacity to regenerate itself due to the avascular nature of cartilage and the failure of chondrocytes to migrate to the injury site 1, 2 . There are many clinical options for the treatment of articular defects ranging from simple symptomatic relief with analgesia to complex procedures including arthroscopic chondroplasty, which aims to remove cartilage fragments 3 . However, these treatments do not provide long-term reversal of the cartilage defects and leaves patients with considerable disability 3 . Microfracture is another option for cartilage engineering, which involves breaching the subchondral bone to release stem cells into the defect to stimulate fibrocartilage growth 3 . However, presently this technique is limited as the fibrocartilage created has inferior properties compared with the native articular cartilage 4 . Joint replacement may be offered to a patient as a final resort to replace a severe osteoarthritic joint, but this is not a suitable alternative for young patients and has considerable functional limitations even for an inactive individual 3 . For a more effective, long-term solution, techniques replacing chondral lesions with cells which are able to produce cartilage that become fully integrated with host cartilage are being actively investigated. Over the last two decades, tissue-engineering strategies have been called upon to achieve this by combining cells, growth factors and scaffolds with appropriate mechanical stimulation. The aim of this review is to summarise the advances in engineering cartilage and to identify the limitations and challenges that remain to be addressed for successful repair and regeneration of articular cartilage for clinical application.
Discussion

Autologous chondrocyte implantation
Chondrocytes are responsible for the production and maintenance of the extracellular matrix components (collagen Type II and proteoglycans), hence considered a good cell choice for cartilage restoration 1 . The first human tissue engineering application to restore cartilage defects has utilised chondrocytes 3 5 . A recent Cochrane review has highlighted that there is insufficient evidence to draw conclusions on the use of ACI for treating full thickness articular cartilage defects in the knee and that further good quality randomised controlled trials with long-term functional outcomes are required 6 . Furthermore, there are many problems with the ACI technique such as obtaining enough autologous chondrocytes during harvesting, loss of cellular differentiation potential when cultured in vitro, and decreased capacity to produce hyaline extracellular matrix (ECM) 7 . Utilising tissue-engineering and biomaterials principles may refine ACI and allow greater success. Specifically, considering different cell sources, modifying the transport medium of the cells (the scaffold material), providing optimal signalling molecules to produce a stable cell phenotype and appropriate culturing environment though mechanical stimulation ACI are increasingly investigated (summarised in Figure 1 ).
Stem cells
Mesenchymal stem cells (MSCs) are being considered for many tissueengineering applications due to their capacity for self-renewal and multidifferentiation potential. Due to ease of harvesting and the ability to undergo proliferation without losing their capacity to differentiate into articular cartilage, MSCs have been considered ideal for repairing cartilage defects 8 . MSCs obtained from the bone marrow have already been clinically utilised to restore auricular defects 8 . Warkitani et al. obtained 10 ml of bone marrow from the iliac crest and expanded the bone marrow mesenchymal stem cells (BMMSCs) in vitro without any chondrogenic inducing media 8 . After 20 days, the cells were attached to a collagen gel, supplemented with antibiotics and autologous serum, and implanted into the medial femoral condyle defect of 12 patients covered by autologous periosteum. Forty-two weeks after the transplantation, the defects were covered with soft white tissue and hyaline cartilage was partially observed 8 . The arthroscopic and histological grading was better despite no difference in clinical score with the cell-transplanted group compared to the cell free group 8 . The same group utilised BMMSCs for a further 18 patients and demonstrated success for articular defects 9, 10 . The authors have recently confirmed that after 11 years and 5 months, no tumours or infections have been reported in the 41 patients followed, highlighting the long-term safety of the procedure 11 . In addition, Nejadnik et al. has recently compared ACI against BMMSCs and found no difference in clinical outcomes at 24 months in 72 matched (lesion site and age) patients 12 .
Other sources of stem cells are being considered including adipose stem cells (ADSCs) and embryonic stem cells (hESCs). ADSCs have been shown to differentiate into chondrocytes and produce cartilage specific matrix components 13 . With greater abundance, easier isolation method and reduceddonor site morbidity than BMMSCs several studies are highlighting the potential for these cells in cartilage engineering 13 . However, the reliability of chondrogenic differentiation of ADSCs and the optimal method for inducing differentiation is still to be identified before utilisation of such cells in clinical studies 14 . Furthermore, studies have shown decreased chondrogenic potential of ADSCs compared with BMMSCs 14 . The use of hESCs is considered to be a favourable option as the cells could be used as an "off the shelf" product, omitting the need for the harvesting procedure and decreasing cost and donor site morbidity. However, current culturing techniques of hESCs have shown limited capability of providing large quantities of chondrocytes, with 15 .
Scaffolds
There are a multitude of natural and synthetic polymers being considered for cartilage tissue engineering. Natural polymers including collagen, silk, chitosan, cellulose, hyaluronic acid, fibrin glue have been utilised for cartilage engineering. Synthetic polymers includingpolylactic acid (PLA), polyglycolic acid (PGA) and polyethylene glycol (PEG) have been used to form cartilage scaffolds. Biomaterial scaffolds must be able to provide a structure to support cell attachment, migration, proliferation, differentiation and production of a cartilage matrix until new cartilage is formed 16 . Biodegradable polymers are considered to be a favourable option as the polymer does not need to be removed through a surgical procedure at a latter date 17 . Porosity, pore size and interconnectivity of scaffold materials are important parameters to consider when choosing the material as they determine chondrocyte migration and diffusion of nutrients and oxygen which support cell function 18 . Insufficient oxygen and nutrient delivery to the centre of the scaffolds may lead to cell death if the scaffold is not porous enough 18 . However, a highly porous structure may begin to limit the mechanical properties of the scaffolds, illustrating an important balance between stiffness of the scaffolds and cell viability 18 . Stiffness of scaffolds has shown to be important in determining cell morphology with rounded chondrocytes shape on weaker substrates but positive stress fibre formation on stiffer substrates 19 . The correct biomaterial scaffold for optimal cartilage tissue engineering is still to be determined; however, collagen and hyaluronan based scaffolds have begun to be tested clinically.
Collagen is a physiological component of many tissues and has been extensively studied for cartilage tissue engineering. A commercially available collagen-based biomaterial, termed Chondro-Gide or Autologous MatrixInduced Chondrogenesis (AMIC®), has been clinically implemented already. Chondro-Gide has been utilised in 57 patients for chondral defect size averaging 3.4 cm 2 (range 1.0-12.0 cm 2 ) 20 . After 2 years of follow-up, the majority of patients were found to be satisfied with their postoperative outcome, reporting a significant decrease in their pain scores (mean visual analogue scale (VAS) preop = 7.0; 1 year postop = 2.7; 2 years postop = 2.0) 20 . In support of this study Anders et al in 2013 reported the combined treatment of ChondroGide(®) with microfracture to be a valid and safe cartilage repair option for small-to medium-sized cartilage defects of the knee 20 . However, further studies with long-term follow-up are needed to determine whether the grafted area will maintain structural and functional integrity over time 21 . Hyaluronan-based scaffolds have also been investigated for cartilage engineering due to its high concentration in the native ECM of articular cartilage. Hyalog raft ® C, a commercially available hyaluronan based scaffold, has shown to support cartilage repair in the midterm 22 . Fillardo et al. illustrated good clinical outcomes at 7 years in 62 patients with chondral lesions of the femoral condyles with an average size of 2.5 ± 1.0 cm 2 treated with arthroscopic implantation of the bioengineered tissue 22 . A better outcome was found in young active men without prior surgery 22 . Further randomised clinical trials with long-term follow-up are still required to confirm the efficacy of such scaffolds for articular reconstruction.
Signalling molecules
Several chemical stimuli including cytokines, growth factors and hormones have shown important in vivo for regulating chondrocyte behaviour. There, a number of growth factors including transforming growth factor (TGF-β), insulin-like growth factor (IGF-1), bone morphogenetic proteins (BMPs) and fibroblast growth factors (FGFs), which have been considered to promote the chondrocyte phenotype 23, 24 . Growth factors from the TGF-β family have shown to play an important role in chondrocyte proliferation, apoptosis and differentiation. TGF-β1 has produced a hyaline cartilage by enhancing collagen Type II and glycosaminoglycan expression whilst reducing collagen Type I expression from stem cells 23, 24 . BMPs have shown to be important in both chondrogenesis and osteogenesis 23, 24 . BMP-4 transduced MSCs have acquired a chondrocytic phenotype in vitro and significantly improved articular cartilage repair in rats 25 . BMP-7 transfected BMMSCs have shown the capability of expressing glycosaminoglycan and collagen Type II 26 . IGF-1 is important for proteoglycan synthesis and breakdown of chondrocytes and cell homeostasis 27 . The combined treatment of BMP-2 and IGF-1 has enhanced chondrogenesis of ADSCs, which showed mature chondrocyte-like cells and formed cartilage nodules 27 . These cells also produced Type II collagen with a reduced production of matrix metalloproteinase-3 27 . Despite the amount of research into these signalling molecules, several questions remain regarding their potential use in cartilage regeneration. For instance, the optimal choice of specific growth factor, importance of co-delivery of growth factors, the dosage required and long-term efficacy of these stimulating factors remain unknown. Ha et al. performed a Phase I clinical trial for localized delivery of allogeneic chondrocytes expressing TGF-β1 directly to the damaged knee joint, TissueGene-C (TG-C) 28 . Untransduced human chondrocytes (hChonJ cells) were also incorporated into the TG-C product at a 3:1 ratio to help fill in the defect and as target cells for the actions of the expressed TGF-β1 28 . Knee evaluation scores seemed to indicate a dose-dependent trend toward efficacy; however, patient numbers were not sufficient to determine statistical significance 28 and minor localised reactions such as warming sensation or itching was also observed in a dose-dependent manner at the injection site 28 . It is clear that further understanding is required before growth factors can be clinically used to maintain a chondrocyte phenotype in human studies.
Mechanical stimulation
The optimal goal of tissue engineering cartilage is to produce cartilage, which mimics the original tissue function and structure. Recently, mechanical stimulation has shown to be important in the development of functional cartilage tissue 29 . Articular cartilage in vivo is affected by several mechanical forces including direct compression, tensile and shear forces, and hydrostatic pressure 30 . These mechanical forces are required to maintain cartilage structure and function 30 . How chondrocytes sense these biomechanical forces and convert them into intracellular signals is currently under extensive investigation in hope to fully appreciate the mechanisms behind load-induced changes in cells.
Cells sense mechanical forces from the ECM by converting them into biological signals by restructuring their cytoskeleton 29 . Mechanical stimuli are detected by transmembrane receptors (integrins) acting as a bridge between the cytoskeleton and the ECM 29 . Once these mechanotransduction pathways are triggered their regulate gene expression and protein production, consequentially controlling cell apoptosis, migration, proliferation, differentiation and the release of various autocrine/paracrine molecules 29 . Mechanical stimuli can also be transduced to the cell by the activation of various cell membrane ion channels and transporters 29 . For example, an influx of Ca 2+ has been reported following cell deformation from shear stress and hydrostatic pressurisation, which is known to act as a second messenger in numerous signalling pathways 29 .
Most investigations into the effect of mechanical stimulation on chondrogenesis apply either static or dynamic uniaxial compression to mimic the direct compression of two joint surfaces in vivo 31 . Dynamic compression has increased the glycosaminoglycan and hydroxyproline content of chondrocytes grown on agarose gels, which results in a tissue with a greater elastic modulus 32 . Dynamic compression has also induced MSC chondrogenic differentiation and increased collagen II and aggrecan expression 33 . As a joint is loaded, hydrostatic pressure (HP) is exerted from the interstitial fluid in the joint 34 . Cyclic and static HP has shown to increase chondrocyte production of matrix components 35 . HP combined in the presence of TGF-β with has also been applied to MSCs and been reported to effectively instigate differentiation towards a chondrocytic phenotype 36 .
To mimic the natural environment, bioreactors are now being explored to induce combined complex types of mechanical stimuli 37 . Bioreactors systems replicate the in vivo environment providing precise control on nutrient transport growth factors, oxygen tension and mechanical stimulation 37 . Traditionally bioreactors were thought to precondition implants to improve their quality before implantation 37 . However, bioreactors have provided the opportunity to study the cellular response to mechanical stimulation under precise conditions 32 . For instance, bioreactors that induce shear stress and compression have shown to enhance the production of the ECM components by human chondrocytes including collagen Type II, sulphated glycosaminoglycan and hydroxyproline content 38 . The present understanding of how mechanical stimuli affects cartilage regeneration is still limited predominantly by (1) the type of load applied in studies being varied which makes comparisons difficult, (2) the use of custom-built machines that are not validated making comparisons problematic and (3) the limited knowledge of how in vivo cells respond to multiple mechanical forces 32 .
Conclusion
Tissue engineering is beginning to provide alternative solutions for healing damaged articular cartilage. However, there are still many issues that need to be addressed before engineered cartilage is a clinical therapy. The optimal cell source needs to be determined for in vivo cartilage engineering. Although stem cells are favourable over chondrocytes due their abundance and ease of isolation, the capacity of longterm cartilage formation with original function and structure must be determined. Second, the optimal scaffold to support in vivo chondrogenesis remains to be defined with several natural and synthetic scaffolds materials currently emerging and being investigated. Though a few natural scaffolds have been tested clinically, lack of in depth clinical evidence highlights that current biomaterials are not fulfilling all the requirements for effective cartilage engineering. The use of signalling molecules such as growth factors is still in its infancy with multiple questions remaining about correct choice, need for multiple simultaneous growth factors, and optimal dosages. The role of mechanical stimuli in cartilage formation has become an important and extensively researched area of work with evidence demonstrating that mechanical stimuli aids in the production of cartilage with appropriate mechanical properties and ECM components. However, further understanding into how cells translate biomechanical stimuli will allow researchers to provide the correct mechanical stimuli for optimal cartilage engineering. With these ongoing developments, cartilage tissue engineering will provide the future techniques to repair articular cartilages for the clinical setting.
